APA websites
Home » Healthcare reform
 

Reduce the affect of arthritis with physiotherapy

DURING last month's World Arthritis Day, the Australian Physiotherapy Association called for increased treatment access for sufferers. Osteoarthritis (OA) is the most common chronic joint disease, and one of the leading causes of pain and disability in Australia.

Protection of ‘physio’ title mandatory for consumer safety

The Australian Physiotherapy Association (APA) recently made a submission to the Federal Government in response to its call for consultation on a range of health reform issues that will affect changes to the Health Practitioner Regulation National Law Act. The APA called on the government to protect the term ‘physio’ to reassure the public that practitioners using this term are fully qualified, registered physiotherapists using evidence-informed treatments. 

Less imaging for back pain

A new educational topic on low back pain from NPS MedicineWise could reframe the role of imaging in diagnosing non-specific low back pain, providing practice tips on how to manage consumer beliefs and expectations.

Physiotherapy should be first-line treatment for hip and knee OA, not surgery

Osteoarthritis, or OA, is the most common form of arthritis, affecting more than 2.1 million Australians.

Funding for physiotherapy led exercise programs is key to proper OA management

Osteoarthritis (OA) is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia’s population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 20301.

APA calls on federal government to fund physiotherapy as first line treatment for osteoarthritis

Osteoarthritis (OA) is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia’s population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.

Lack of funds hits digital health options for arthritis sufferers

The Australian Physiotherapy Association says a lack of funds is preventing arthritis sufferers in the country — whose treatment costs $23.9 billion every year — from being treated with digital health options which have been found to be effective.

Future of physiotherapy practice a focus of NEXT 2018

Top business minds, leading clinicians and strategic innovators will converge on Hobart’s waterfront this week as part of the Australian Physiotherapy Association’s (APA) NEXT conference, aimed at the profession’s business, education and practice leaders.

Orkambi® PBS listing provides quality of life to CF patients

The Australian Physiotherapy Association (APA) welcomes the announcement this week by federal Health Minister Greg Hunt that the cystic fibrosis (CF) drug Orkambi® will be added to the PBS effective October 1 2018. Access is available to families immediately as a result of a compassionate request from the government to drug manufacturer Vertex.

Physios support RACGP recommendations for exercise management of OA

New guidelines released yesterday by the Royal Australian College of General Practitioners (RACGP) and co-authored by Australian Physiotherapy Association (APA) member Professor Kim Bennell from the University of Melbourne confirm that exercise and weight management should be the first treatment options for Australians living with debilitating knee and/or hip osteoarthritis (OA).

Pages

APA Partners